APA (7th ed.) Citation

Shin, D., Ha, S., O, J. H., Rhew, S. a., Yoon, C. E., Kwon, H. J., . . . Lee, J. Y. (2022). A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [ 177 Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial. Cancers, 14(24), 6225. https://doi.org/10.3390/cancers14246225

Chicago Style (17th ed.) Citation

Shin, Dongho, et al. "A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [ 177 Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial." Cancers 14, no. 24 (2022): 6225. https://doi.org/10.3390/cancers14246225.

MLA (9th ed.) Citation

Shin, Dongho, et al. "A Single Dose of Novel PSMA-Targeting Radiopharmaceutical Agent [ 177 Lu]Ludotadipep for Patients with Metastatic Castration-Resistant Prostate Cancer: Phase I Clinical Trial." Cancers, vol. 14, no. 24, 2022, p. 6225, https://doi.org/10.3390/cancers14246225.